HOME > BUSINESS > Dr Reddy’s hit by class action suit on “misleading statements” on FDA action

Dr Reddy’s hit by class action suit on “misleading statements” on FDA action

Pharma giant Dr Reddy’s Labs today said that a class action lawsuit has been filed against it on behalf of shareholders, alleging that the company misled investors causing them to lose money on their investments.

“The lawsuit alleges that the company made materially false and/or misleading statements or omissions in connection with its corporate quality system, and specifically in connection with a warning letter from the US Food and Drug Administration dated November 6, 2015, and a letter from the Regierung von Oberbayern in Germany dated Aug 10, 2017,” the company said.

“The lawsuit seeks damages to compensate the purported class of investors for a purported decline in the company’s share price allegedly caused by the alleged misstatements and omissions,” it said today, adding that it has not been served with the lawsuit yet.

The shares of the company fell 2.3% on Monday on the NSE in India.

The case was filed on Aug 25 in the United States District Court for the District of New Jersey.

The suit has been filed on behalf of investors who purchased the company’s shares on the New York Stock Exchange between June 17, 2015 and August 10, 2017, the company said.

“The company cannot comment on the specific allegations in the pending litigation other than to state that the company believes the asserted claims to be without merit,” Dr Reddy’s Labs said.

“The company will respond to the allegations after it has been served with the lawsuit and as and when it may be required to do so by the court,” Dr Reddy’s added.

Separately, on Friday, US-based Rosen Law Firm said it had filed a class action lawsuit on behalf of purchasers of Dr. Reddy’s Laboratories Ltd. to recover damages for Dr. Reddy’s investors under the federal securities laws.

Follow ULTRA.news
RCom sends legal notice to rivals for spreading rumors Anil Ambani Group's Reliance Communication said it has sent 'cease and desist' notices to its rivals trying to win over its enterprise customers by creating fear about the company shutting down.The development comes in the wake of announcements by the company that it was gra...
HCL Infosystems gets tax notice for Rs 312 cr plus penalties HCL Infosystems, the India-focused IT arm of HCL Group, said it received a tax demand of Rs 312.34 cr plus interest and an amount equal to the interest amount as penalty.The company, which is already struggling with losses, did not specify the amount of interest involved or ...
Lupin gets USFDA warning on Goa, Indore plans, to affect new approvals Pharma major Lupin said it a warning letter from the US Food and Drug Administration for its formulations manufacturing facilities in Goa and Indore on Monday."We are deeply disappointed to hove received this outcome. While there will be no disruption of existing product sup...
LIC withdraws insolvency case against DB Realty Life Insurance Corporation of India, the single biggest shareholder in many listed companies in India, has withdrawn its insolvency case against DB Realty Ltd, the real estate developer said.The two companies have executed a debt settlement agreement on Oct 16, DB Realty sai...
Unichem Labs Ghaziabad plant inspected by USFDA Generic drug manufacturer Unichem Laboratories said its formulations manufacturing facility at Ghaziabad has successfully exited an inspection by the US Food and Drug Administration.Inside a Unichem plantIt received an Establishment Inspection Report (EIR) from the USFDA...
Zydus Cadila gets USFDA approval for generic form of colitis drug Lialda Zydus Cadila said the US Food and Drug Administration has given the final approval to market the company's Mesalamine Delayed-Release Tablets in the US market.Zydus Cadila was the first to file an Abbreviated New Drug Application (ANDA) for a generic version of Lialda.L...
Kapil Mishra to file FIR against Arvind Kejriwal Estranged Aam Aadmi Party leader Kapil Mishra said he will file a police complaint against Arvind Kejriwal today.The rebel AAP leader has accused the party supremo of taking bribes and acting like a dictator within the party."It is with a heavy heart that I am doing this,...
Supreme Court refuses to change decision in Saumya murder case GovindaswamyThe Supreme Court has dismissed a curative petition filed by the Kerala Government against its decision finding the main accused not guilty in the prominent Saumya rape and murder case of Kerala.The case, analogous to the Nirbhaya episode of Delhi, had shocke...
Nokia files more patent infringement suits against Apple Nokia has filed further complaints alleging that Apple products infringe a number of Nokia patents, expanding its litigation originally announced on December 21. Across actions in 11 countries, there are now 40 patents in suit, which cover technologies such as display, us...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
Welspun says ‘Egyptian Cotton’ related US lawsuits not yet material Welspun said it believed that two complaints against the company for allegedly using non-Egyptian cotton may or may not be allowed to proceed as class action lawsuits, and are therefore not yet 'material'.The company was responding to a question by the stock exchanges of Indi...
Sharon Bio Medicines receives FDA approval for Tajola API plant Indian Pharmaceutical company Sharon bio medicine Ltd said it received the Establishment Inspection Report (EIR) from United States Food and Drug Amnistration for its manufacturing plant located at Tajola in Raigad Dist., Maharashtra.The plant, which will make Active Pharmace...
Dr Reddy’s Laboratories launches Paricalcitol injection in the US Market Dr. Reddy's Laboratories Ltd said it launched Paricalcitol Injection, a therapeutic equivalent generic version of Zemplar injection in the United States market approved by the US Food & Drug Administration (USFDA).The Zemplar brand and generic had US sales of approximatel...
Wipro says ESIC withholds dues under contract IT provider Wipro Ltd said Indian government's Employees' State Insurance Corporation has withheld payments due to it after the completion of a project, and it will take legal action to recover the amount.The seven-year contract, named Project Panchdeep, was completed on June...
ACC, Ambuja to challenge Competition Commission order ACC Ltd and Ambuja Cements said they will challenge the fine imposed by the Competition Commission of India yesterday, and that a similar order passed by the CCI four years ago had been set aside by the Competition Appellate Tribunal in December last year."We await receip...
Dr. Reddy’s Laboratories launches heart drug in the US Pharma company Dr. Reddy's Laboratories Ltd said it launched Nitroglycerin sublingual tablets -- a therapeutic equivalent generic version of Nitrostat sublingual tablets -- in the US market.The medication is used before physical activities (such as exercise, sexual activity) ...
Finance Ministry DID NOT reject Tata arbitration payment – DoCoMo Japanese telecom major DoCoMo said it was not aware of any new decision by the finance ministry on the issue of payment of arbitration amount by Tata Sons.A report by the Press Trust of India yesterday claimed that the Finance Ministry had rejected a proposal by the Reserve B...
DoCoMo reiterates Tata Sons must pay $1.17 bln DoCoMo, the Japan-based telecom group and a partner of Tata Sons in their telecom venture in India, said there are no impediments for Tata Sons to pay the penalty awarded by the London Court of International Arbitration.DoCoMo said Tata Sons should not use a recent decision b...
Nestle says will work with govt to bring Maggi back Nestle welcomed the decision by the Bombay High Court to lift the ban on Maggi noodles imposed by Food Safety and Standards Authority of India and said it expects to see the product back on shelves soon."(We) will comply with the order to undertake fresh tests," Nestle said o...
TV Today, NDTV confirm receipt of show-cause notice over Yakub Memon’s execution NDTV and TV Today said they had received show cause notices from the ministry of information and broadcasting for airing programs on the suitability of the death penalty for Yakub Memon, who was hanged to death last week."The Company firmly believes that it has not violated a...